Magnetic Resonance Elastography Study of Brain Tumors
The primary objective of the study is to compare the effect of 90-day treatment with
ticagrelor (180 mg [two 90 mg tablets] loading dose on Day 1 followed by 90 mg twice daily
maintenance dose for the remainder of the study) vs acetylsalicylic acid (ASA)-aspirin (300
mg [three 100 mg tablets] loading dose on Day 1 followed by 100 mg once daily maintenance
dose for the remainder of the study) for the prevention of major vascular events (composite
of stroke, myocardial infarction [MI], and death) in patients with acute ischaemic stroke or
transient ischaemic attack (TIA).
View more details from ClinicalTrials.gov.
For more information about a clinical trial, clinical trial eligibility, or informed consent, contact our research nurses by phone or email:
Please Note: Any eligibility criteria noted are subject to change. Our research nurses can provide you with the most current eligibility and exclusion criteria. Any study involvement to be undertaken must ultimately be determined on an individual basis.